| Literature DB >> 34332601 |
Alex Waddell1,2, Alyse Lennox3, Gerri Spassova4, Peter Bragge3.
Abstract
BACKGROUND: Involving patients in their healthcare using shared decision-making (SDM) is promoted through policy and research, yet its implementation in routine practice remains slow. Research into SDM has stemmed from primary and secondary care contexts, and research into the implementation of SDM in tertiary care settings has not been systematically reviewed. Furthermore, perspectives on SDM beyond those of patients and their treating clinicians may add insights into the implementation of SDM. This systematic review aimed to review literature exploring barriers and facilitators to implementing SDM in hospital settings from multiple stakeholder perspectives.Entities:
Keywords: Barriers and facilitators; Hospital care; Implementation; Shared decision-making; Theoretical Domains Framework
Year: 2021 PMID: 34332601 PMCID: PMC8325317 DOI: 10.1186/s13012-021-01142-y
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Inclusion and exclusion criteria
| Included | Excluded | |
|---|---|---|
Patients aged 18 and over Healthcare providers Healthcare administrators Healthcare decision makers Government policy makers Other stakeholders (including researchers, not for profit organisations) | Patients aged under 18 years | |
| SDM in hospital inpatient setting, in which the decision is made while the patient is an inpatient or in emergency | Non-SDM interventions Decisions made in primary or secondary care settings | |
| Primary studies where barriers and facilitators are qualitatively reported | Editorials Randomised control trials Quantitative studies Non-peer-reviewed studies Reviews (reviews were not included, but their reference lists were searched for additional primary studies) | |
| Barriers and facilitators to implementing SDM in inpatient hospital settings where the decision is made while the patient is an inpatient, reported in the results section | Effectiveness of SDM interventions Impact of SDM interventions Preferences for decisions | |
| Qualitative, mixed methods (qualitative only) | Quantitative, mixed methods (quantitative) |
Fig. 1PRISMA diagram. *Of the 520 articles reviewed, n = 33 were excluded as the primary aim was not implementing SDM, n = 180 were excluded as the primary focus was not barriers and facilitators to implementing SDM, n = 68 were excluded as they did not qualitatively assess the barriers and facilitators to implementing SDM, n = 6 were excluded for using the wrong patient population, n = 98 were excluded as the context was not inpatient hospital, n = 11 duplicates were identified and excluded, n = 99 were the wrong study type. n = 1 study was excluded as the author did not respond to questions regarding methodology pertinent to study eligibility. ^n = 24 studies were included after full-text review, including n = 10 systematic reviews that were screened for additional studies, no additional studies were found.
Fig. 2Included published studies by year
Barriers and facilitators to implementing SDM data mapped to the Theoretical Domains Framework (Cane et al., 2012) from multiple perspectives
| Stakeholder group | Clinician-related factors | Patient-related factors | Health service administrators (HSA), Decision makers (HSDM), Government policy makers (GPM), and other stakeholder-related factors | Organisational-level factors | System-level factors |
|---|---|---|---|---|---|
| 1. | |||||
| Barriers | - Not knowing what SDM is [ - Incorrect definition of SDM [ - Assumes patient understands information shared [ - Does not know true risk of options [ | - Limited or no knowledge of disease or options [ - Limited understanding of risk [ - Not provided adequate information for decision [ - Provided biased information [ - Not understanding jargon used by clinicians [ - Not knowing own patient history (i.e. previous drug treatment) [ - Not having knowledge of language to describe their experience of illness [ | - Lack of guidelines that include SDM [ | ||
| Facilitators | - Understanding of SDM and what it entails [ - Understanding of risks and benefits for treatment options [ | - Well informed about the disease and treatment options prior to the SDM conversation [ - Patient is able to understand consequences and risks of alternatives [ - Knowledge of previous treatments for condition (i.e. which drugs they had been treated with previously) [ | - Use posters/reminders to create awareness of SDM implementation programme [ - Tailored information services for patients [ | - Support cross-site learning through regular meetings [ - Pool information from separate SDM initiatives to speed knowledge translation [ - Promote awareness of the benefits of SDM through research [ - Promote patient awareness of SDM through national campaign [ | |
| 2. | |||||
| Barriers | - Lack of training in SDM [ - Lack of communication skills [ - Lack of skills to train junior doctors in SDM [ - Overreliance on clinical algorithms for determining treatment decisions [ | - Decision is left to the patient [ - Informational capacity to make informed decisions (barrier and facilitator) [ | - Senior clinicians are expected to teach junior doctors how to do SDM without having training themselves [ | - Lack of training to do SDM [ | |
| Facilitators | - Communication skills, i.e. ability to explain risks and benefits of treatment option [ - Formal training in SDM [ - Trust in one’s own clinical skills and ability [ - Awareness of one’s own limitations as a clinician [ - Has been given education in communication with patients [ - Uses evidence-based data to inform treatment options [ - Experience increases clinical skill and confidence [ - Providing tailored information to patients based on their informational needs [ | - Informational capacity to make informed decisions (barrier and facilitator) [ - Ability to speak up for own preferences due to prior experience in health setting (i.e. as nurse or long-term patient) [ | - Require full team interdisciplinary training to ensure language is the same across disciplines when implementing SDM [ - Provide training on use of Patient Decision Aids [ - Opportunity to practice SDM with senior clinicians [ | - SDM is part of medical student’s education [ - Including patients in SDM education [ - Support cross-site learning through regular meetings [ | |
| 3. | |||||
| Barriers | - Clinicians belief that their role is to make decisions and convince patients [ - Not wanting to seem indecisive [ - Belief that colleagues do not want to do SDM [ - Patient has no or limited ongoing primary care [ | - Belief that clinician’s role is to make decisions [ - Belief that nurses should not be involved in SDM [ - Not wanting to be labelled “difficult” [ - Perceived unacceptability of asking clinician questions [ - Social stigma of having and seeking treatment for mental illness [ | |||
| Facilitators | - Clinician sees role as educator of patients [ - Clinician sees role as collaborator with patient [ - Asks for patient’s preferred role in SDM [ - Interprofessional collaboration—clear communication [ - Nurse is involved in SDM [ | - Has positive/trusting relationship with clinician [ - Belief that it is their role to be involved in decision-making with clinician (i.e. asks questions) [ - Feeling more comfortable speaking with allied health (i.e. pharmacist) [ | HSA, HSDM-related factors - Manages implementation through actively anticipating personnel/budget shifts [ - Sees duty in aiding implementation of SDM through knowing appropriate education is being provided to clinicians and patients [ Other stakeholder-related factors - Engage new policy makers in SDM [ | - Engage new clinicians/patients in SDM [ | - Include SDM in professional role descriptions for clinicians [ - Showcase innovators of SDM [ - Show patients their role in SDM through national campaigns [ |
| 4. | |||||
| Barriers | - Clinician belief that patient does not want to “do” SDM [ - Clinician belief that the patient will make the wrong choice [ - SDM is too much effort [ | - Patient belief that patients should not disagree with the clinician [ | - Belief that change is too difficult, takes too long, too many resources needed [ | - Change is too difficult, takes too long, too many resources needed [ | |
| Facilitators | - Belief that patients should be involved in decisions about their own care [ - Risk is part of medicine [ - Acknowledges own biases that may interfere with decision-making [ | - Belief that patients should be involved in decisions about their own care [ | |||
| 5. | |||||
| Barriers | - Belief that colleagues will not want to do SDM [ - Belief that SDM carries increased risk of litigation [ | - Lack of confidence in their clinician and/or outcome [ | Change is too difficult, takes too long, too many resources needed [ | ||
| Facilitators | - Having trust and patience in the treatment decision and expecting a good outcome [ | ||||
| 6. | |||||
| Barriers | - Fear of a negative outcome [ - Disease is too acute for SDM [ - Lack of applicability of the clinical situation [ | - Fear of negative consequences of the eventual decision [ | |||
| Facilitators | - SDM reduces healthcare utilisation [ - SDM aids decision-making [ - SDM improves relationships between clinicians and patients [ - SDM increases patient satisfaction and sense of control [ - SDM eases the burden on clinicians (i.e. makes work easier) [ - Including patients in SDM reduces the likelihood of litigation [ | - Patient decision aids can help stimulate SDM conversations in busy environments [ | |||
| 7. | |||||
| Barriers | - Potential for litigation [ - Not motivated by patient satisfaction metrics [ - Not motivated by the potential benefits of practising SDM [ - Not motivated by reduced healthcare utilisation [ | - Quality assurance tools do not promote SDM [ | - Risk of litigation for clinical mistakes [ - Lack of reward for doing SDM [ | ||
| Facilitators | - Motivated by patient satisfaction [ - Positive experiences engaging patients in SDM [ | - Changing legislation to reduce clinician’s risk of being sued for mistakes [ - Use financial incentives to reimburse time spent doing SDM [ - Include SDM in professional audits [ | |||
| 8. | |||||
| Barriers | - Deciding the treatment plan before speaking to the patient [ - Intending to “sell” the patient on the chosen treatment option [ - Compliance as motivator [ - Intentionally not engaging in SDM when junior doctor is the first to see the patient [ - Leaving the patient to make the decision [ | - Non-adherence with treatment plan [ | - Teams deciding together on the best course of action without input from the patient [ - Not replacing personnel in charge of SDM programme [ - Not providing support coverage for nurses to attend SDM training sessions [ | ||
| Facilitators | - Intentionally asking patient preferences [ - Seeking to understand and alleviate patients concerns [ - Seeking to understand individual needs of the patient [ - Wanting to reduce harms of unnecessary and potentially harmful testing (i.e. CT scan) [ | - Being open and honest with clinician about feelings, fears and preferences [ - Asking questions and providing feedback about symptoms/treatment [ - Being open and honest in discussions around treatment [ - Deciding to cooperate with treatment plan [ | - Facilitate connections between multiple SDM implementation sites i.e. through community of practice [ | ||
| 9. | |||||
| Barriers | - Patient lack of engagement or ambition [ | ||||
| Facilitators | - Seeking to implement SDM using Patient Decision Aids [ | - Bringing individual programmes together with the goal of sharing learnings in order to facilitate knowledge creation [ | |||
| 10. | |||||
| Barriers | - Interruptions make it difficult to concentrate on engaging in SDM [ - Competing priorities, i.e. highly acute patients/time make it easier to order more tests rather than engage in SDM [ - Reliance on algorithms to make clinical decisions [ | - Significant decision—difficulty being objective [ | Fear that implementing SDM will interrupt workflows [ | ||
| Facilitators | - SDM draws attention to clinician’s own biases [ - Significant decision requires additional attention and patient preference [ | - Increased attention recognising it is a significant decision [ | |||
| 11. | |||||
| Barriers | - Condition is too acute for SDM [ - Lack of time to engage in SDM [ - Noisy or busy ward environment [ - Lack of private space to conduct SDM conversations [ - Patients often placed in hallways (not feasible for SDM conversation) [ - Presence of family/carers [ - Clinician characteristics [ - Interprofessional collaboration allows for more time for the decision to be made [ | - Patients characteristics such as lower socioeconomic status, multiple comorbidities, lack of clinician language, past negative health experiences [ - Lack of primary care physician to follow up with treatment decisions [ - Not having sufficient time for decision-making [ | HSA, HSDM-related factors - Implementing SDM will take too much time, or too many resources [ Making changes within the healthcare system is too difficult [ | - Noisy or busy ward environment [ - Lack of private space to conduct SDM conversations [ - Patients placed in hallways (not feasible for SDM conversation) [ - Not enough clinicians [ - Waiting time to see clinician [ - Resources not available to use Patient Decision Aids [ - No process for contacting primary care physicians on discharge [ | - Inadequate funding of SDM [ - Lack of agreed national plan for SDM [ - Lack of clinical guidelines supporting SDM/fragmented availability of guidelines [ - Lack of decision-making materials (i.e. patient decision aids) [ - Part of policy, but not enforced i.e. through quality measures [ |
| Facilitators | - Clinical equipoise of treatment decision [ - Low acuity, meaning more time for SDM discussion [ - Including the family in SDM [ - Including the patient in decision-making as soon as possible (i.e. when first arriving on the ward) [ - Using communication tools that explain risk [ - Having minimal people involved in SDM conversation, as too many people can bring in different opinions [ | - Patients characteristics such as higher socioeconomic status, education, health literacy [ - Presence of a carer/family [ - Carer/family providing translation support [ - Using question prompt lists [ | HSA, HSDM-related factors - Past negative experience with SDM [ Other stakeholder-related factors - Monitor SDM implementation [ | - Any SDM intervention is supported by evidence-based literature [ - Using a standardised channel (i.e. form) for sharing information across teams [ - Ensure forms can be modified in line with needs of the team [ - Private spaces to conduct SDM [ | - Change guidelines to promote use of SDM in clinical practice [ - Create locally based, context-specific SDM implementation evidence [ - Research into the specific benefits of SDM tools [ - Allow patient access to medical records [ |
| 12. | |||||
| Barriers | - Senior clinicians not engaging in SDM [ - Other clinicians not engaging in SDM [ - Inconsistent messaging between interprofessional team members [ | - Perceived power imbalance between the clinician and patient [ - Family pressure to choose a particular treatment option - Cultural beliefs [ | HSA, HSDM-related factors - Not having a site champion/leaders to endorse implementation of SDM [ | - Lack of team support for clinician to do SDM [ - Lack of organisational role models promoting SDM [ | - Lack of support from policy makers [ |
| Facilitators | - Senior clinicians engaging in SDM [ - Consistent messaging between interprofessional team members [ | - Culture of the organisation supports SDM [ - Leadership engages in SDM [ - Conduct regular SDM implementation team meetings [ - Establish site champions for SDM [ | |||
| 13. | |||||
| Barriers | - Fear of “missing something” [ | - Fear of uncertain or negative outcomes [ - Patient being perceived by the clinician as being “rude” or “aggressive” or not open to SDM [ - Fear of being labelled difficult [ - Feeling like clinicians are not listening to concerns [ - Feeling stressed due to busy or noisy ward environment [ - Family members are emotional and stressed [ - Feeling powerless during involuntary admission [ - Reduced desire to engage in active decision-making (due to illness) [ | |||
| Facilitators | - Feeling listened to [ - Patient being calm and respectful [ | ||||
| 14. | |||||
| Barriers | - Not following treatment plans [ | ||||
| Facilitators | - Clinician taking a full medical history to encourage patient preferences [ | - Following treatment plan [ - Asking to be involved in decision-making [ - Asking questions in the consultation [ - Opposing treatment recommendations [ - Researching own illness/treatment [ - Giving feedback on treatment experience [ | - Change clinician habits through changing care processes to include patient preferences [ - Create mandatory reporting of SDM implementation programmes [ - Posters around ward to remind nurses of SDM implementation [ - Engaging all patients in decision-making as soon as possible when they enter the ward [ | ||
Summary of review findings for dominant themes
| Summary of review findings | CERQual assessment of confidence in the evidence |
|---|---|
[ | High confidence |
[ [ | High Confidence |
[ | High confidence |
[ | High confidence |
[ | Moderate confidence |
[ | Moderate confidence |
[ ( [ | High confidence |
[ | Moderate confidence |
[ | High confidence |
[ | Moderate confidence |
[ | Moderate confidence |
[ [ | Moderate confidence |
[ | Moderate confidence |
[ | Moderate confidence |
[ | High confidence |
[ | Moderate confidence |
[ | Moderate confidence |
[ | High confidence |
[ | High confidence |
[ | Moderate confidence |
[ | High confidence |
[ Conversely a number of clinicians hold the [ | High confidence |
[ | High confidence |
[ | Moderate confidence |
Summary of review findings for clinician-related factors
| Summary of review findings for additional clinician-related factors | CERQual assessment of confidence in the evidence |
|---|---|
A number of clinicians decide on the treatment plan before engaging in decision-making conversations, with the intention of “selling” the patient on the treatment they have selected for them [ | High confidence |
Clinicians reported not engaging in SDM when they are concerned about the potential of a negative outcome, sometimes this is due to the acuity of the decision or the potential risks [ [ | High confidence |
Summary of review findings for patient-related factors
| Summary of review finding for additional patient-related factors | CERQual assessment of confidence in the evidence |
|---|---|
[ | Low confidence |
Summary of review findings for organisation- and system-related factors
| Summary of review finding for additional organisation- and system-related factors | CERQual assessment of confidence in the evidence |
|---|---|
[ | Moderate confidence |
[ | High confidence |